Ecomax, Inc. engages in the search for new business opportunities. The company is headquartered in New York City, New York. The company went IPO on 2001-07-12. Rocitin NMN is a nutritional supplement manufactured by Pharmazeutische Fabrik Evers GmbH & Co. KG, a German company. Each bottle contains 60 capsules, 10080 mg of NMN. NMN, as β-Nicotinamide Mononucleotide exists in some fruits, vegetables, and poultry. The company is a molecule naturally occurring in all life forms and can be transformed into a significant coenzyme NAD+ within cells, which is important to human metabolism. Its research, including Nicotinamide mononucleotide (NMN) as an anti-aging health product has shown that NAD+ levels in the body will decrease with age, and that exogenous supplementation of NMN enhances NAD+ levels and thus the function of human cells. In addition, NMN also helps to repair broken DNA, regulate the stability of DNA and cell death, and improve neurodegenerative and metabolic conditions.
Follow-Up Questions
Quelle est la performance du prix de l'action EMAX ?
Le prix actuel de EMAX est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Ecomax Inc ?
Ecomax Inc appartient à l'industrie N/A et le secteur est N/A
Quel est la capitalisation boursière de Ecomax Inc ?
La capitalisation boursière actuelle de Ecomax Inc est de $0
